Neostigmine methylsulfate
These highlights do not include all the information needed to use NEOSTIGMINE METHYLSULFATE INJECTION safely and effectively. See full prescribing information for NEOSTIGMINE METHYLSULFATE INJECTION. NEOSTIGMINE METHYLSULFATE Injection, for intravenous use Initial U.S. Approval: 1939
971713db-d5ac-44c1-ada5-a56a943d79bf
HUMAN PRESCRIPTION DRUG LABEL
Feb 18, 2022
BE Pharmaceuticals Inc.
DUNS: 081499296
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Neostigmine methylsulfate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
Neostigmine methylsulfate
Product Details
FDA regulatory identification and product classification information